The share price is at .35 with a clinical hold and
Post# of 148190
(Total Views: 522)
Posted On: 11/07/2022 4:30:20 PM
The share price is at .35 with a clinical hold and no real news. When things start getting done I expect an increase in share price and a steep jump on preliminary NASH results. Our cost basis for the trial will also be significantly less, maybe $50 million.
(6)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼